AU
CA
NZ
UK
US
IND
Kalkine has a fully transformed New Avatar.
Last update at 2026-03-11T05:10:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Undervalued Small Caps With Insider Buying In Global January 2026
Thu 22 Jan 26, 09:39 AMUndervalued Small Caps With Insider Buying In Global For January 2026
Thu 08 Jan 26, 09:39 AM3 Top Undervalued Small Caps In Global With Insider Buying
Tue 06 Jan 26, 09:39 AMExploring 3 Undervalued Small Caps In Global With Notable Insider Activity
Thu 25 Dec 25, 09:39 AMInsider Buying Highlights Undervalued Asian Small Caps For December 2025
Tue 23 Dec 25, 10:36 PMGlobal's Undervalued Small Caps With Insider Action In December 2025
Tue 23 Dec 25, 09:39 AMAsian Undervalued Small Caps With Insider Action For December 2025
Sun 21 Dec 25, 10:36 PMAsian Undervalued Small Caps With Insider Buying To Consider For Your Portfolio
Thu 04 Dec 25, 10:36 PM3 Undervalued Small Caps In Global With Insider Action To Consider
Fri 02 May 25, 09:39 AMExploring 3 Undervalued Small Caps With Insider Action In Global Markets
Wed 19 Feb 25, 11:08 AM| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Income before tax | 25.46M | 14.05M | 20.85M | 10.69M | 12.33M |
| Minority interest | - | - | -2.80400M | -0.51000M | - |
| Net income | 20.57M | 8.38M | 10.76M | 6.63M | 8.28M |
| Selling general administrative | 38.22M | 87.24M | 70.09M | 60.12M | 50.71M |
| Selling and marketing expenses | 54.36M | 42.33M | 11.21M | 8.70M | 7.24M |
| Gross profit | 324.00M | 176.07M | 126.32M | 102.83M | 90.31M |
| Reconciled depreciation | - | 14.47M | 10.29M | 7.98M | 6.20M |
| Ebit | 59.98M | 28.71M | 27.56M | 20.99M | 19.51M |
| Ebitda | 89.81M | 43.18M | 37.86M | 28.97M | 25.71M |
| Depreciation and amortization | 29.83M | 14.47M | 10.29M | 7.98M | 6.20M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 89.53M | 28.44M | 23.26M | 13.29M | 13.98M |
| Other operating expenses | 3524.36M | 2921.52M | 83.31M | 59.53M | 74.01M |
| Interest expense | 33.17M | 16.24M | 5.93M | 5.70M | 7.17M |
| Tax provision | 4.89M | 5.67M | 5.20M | 3.54M | 4.05M |
| Interest income | 25.96M | 1.63M | 0.38M | 0.13M | 0.02M |
| Net interest income | - | -14.61400M | -6.64000M | -5.97900M | -7.99400M |
| Extraordinary items | - | - | -2.08900M | - | 0.00000M |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 4.89M | 5.67M | 5.20M | 3.54M | 4.05M |
| Total revenue | 3613.89M | 2969.89M | 307.63M | 247.91M | 235.84M |
| Total operating expenses | 234.47M | 127.70M | 102.22M | 84.12M | 72.86M |
| Cost of revenue | 3289.89M | 2793.82M | 181.31M | 145.08M | 145.53M |
| Total other income expense net | -64.06600M | -14.38700M | 3.39M | -2.04700M | 2.87M |
| Discontinued operations | - | - | -2.08900M | 0.34M | 0.34M |
| Net income from continuing ops | - | 8.38M | 15.65M | 7.14M | 8.28M |
| Net income applicable to common shares | 20.57M | 6.75M | 10.76M | 6.63M | 8.28M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Total assets | 1234.05M | 1130.89M | 448.52M | 437.03M | 291.92M |
| Intangible assets | 384.64M | - | 6.73M | 3.36M | 2.37M |
| Earning assets | - | - | - | - | - |
| Other current assets | 52.63M | 3.26M | 1.73M | 9.20M | 0.13M |
| Total liab | 915.04M | 838.97M | 196.56M | 194.69M | 170.40M |
| Total stockholder equity | 319.00M | 291.92M | 242.85M | 236.03M | 121.52M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 22.93M | 22.55M | 29.03M | 27.52M | 25.55M |
| Common stock | 328.49M | 328.49M | 232.30M | 228.66M | 113.95M |
| Capital stock | - | - | 232.30M | 228.66M | 113.95M |
| Retained earnings | -15.87200M | -36.24500M | 10.10M | 7.53M | 8.28M |
| Other liab | - | - | 2.59M | 2.26M | 0.62M |
| Good will | - | - | 252.33M | 241.02M | 149.00M |
| Other assets | - | 0.00000M | 9.72M | 11.31M | 10.84M |
| Cash | 21.90M | 19.94M | 22.60M | 46.20M | 33.20M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 647.64M | 701.92M | 93.55M | 87.38M | 82.21M |
| Current deferred revenue | - | 9.48M | 6.16M | 10.10M | 1.00M |
| Net debt | 274.62M | 231.88M | 99.54M | 85.06M | 79.81M |
| Short term debt | 47.50M | 116.75M | 21.72M | 26.21M | 25.44M |
| Short long term debt | - | - | 17.09M | 22.69M | 21.59M |
| Short long term debt total | 296.52M | 251.83M | 122.14M | 131.26M | 113.01M |
| Other stockholder equity | - | -0.32500M | -242.39900M | -236.18400M | -122.23100M |
| Property plant equipment | - | - | 44.92M | 30.50M | 16.50M |
| Total current assets | 759.79M | 681.52M | 132.65M | 150.84M | 113.21M |
| Long term investments | - | - | 2.17M | 0.26M | - |
| Net tangible assets | - | - | -16.21500M | -8.34900M | -29.85600M |
| Short term investments | - | - | - | - | - |
| Net receivables | 402.71M | 350.58M | 39.43M | 42.92M | 26.20M |
| Long term debt | - | - | 67.60M | 73.40M | 80.40M |
| Inventory | 282.54M | 307.74M | 63.69M | 51.45M | 51.58M |
| Accounts payable | 577.21M | 553.13M | 36.65M | 23.56M | 30.22M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 6.39M | - | 10.55M | 7.38M | 7.57M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 11.12M | 6.08M | - | - | -167.87000M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 474.26M | 449.37M | 315.87M | 286.19M | 178.71M |
| Capital lease obligations | - | - | 37.45M | 35.18M | 11.03M |
| Long term debt total | - | - | 100.42M | 105.05M | 87.57M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Investments | - | -19.52500M | -31.74600M | 7.07M | -18.80300M |
| Change to liabilities | - | - | 3.68M | -14.95700M | 13.71M |
| Total cashflows from investing activities | -16.64100M | -19.52500M | -31.74600M | 7.07M | -18.80300M |
| Net borrowings | - | 13.07M | -15.71900M | -11.44700M | 0.03M |
| Total cash from financing activities | 28.65M | -5.95300M | -10.00200M | -11.93000M | 0.03M |
| Change to operating activities | - | - | -1.06500M | -4.58700M | -1.51600M |
| Net income | 20.57M | 8.38M | 10.76M | 6.09M | 8.28M |
| Change in cash | 1.95M | 18.97M | -23.60000M | 13.01M | 8.69M |
| Begin period cash flow | 19.94M | 0.97M | 46.20M | 33.20M | 24.50M |
| End period cash flow | 21.90M | 19.94M | 22.60M | 46.20M | 33.20M |
| Total cash from operating activities | -11.34800M | 44.45M | 17.75M | 19.03M | 27.46M |
| Issuance of capital stock | - | - | 0.42M | 0.48M | - |
| Depreciation | 29.83M | 14.47M | 8.86M | 7.94M | 6.20M |
| Other cashflows from investing activities | -4.48700M | -12.40400M | -10.70000M | -1.49300M | -0.13400M |
| Dividends paid | 0.00000M | 12.61M | 7.89M | 1.04M | 7.89M |
| Change to inventory | -10.13900M | -6.10900M | -12.43100M | 8.29M | -4.91600M |
| Change to account receivables | -53.55500M | -97.85800M | -1.10100M | 7.72M | 5.87M |
| Sale purchase of stock | - | - | -0.01900M | -0.01900M | - |
| Other cashflows from financing activities | -0.00100M | -7.98100M | 7.46M | -2.48800M | -3.30700M |
| Change to netincome | - | - | 3.25M | 7.32M | -0.16300M |
| Capital expenditures | 11.69M | 19.32M | 21.05M | 4.61M | 5.29M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -80.63200M | 19.70M | -13.53200M | -5.15600M | 9.23M |
| Stock based compensation | 0.98M | - | 0.35M | 0.85M | 0.07M |
| Other non cash items | 17.89M | 1.90M | -1.87200M | 7.14M | -0.23200M |
| Free cash flow | -23.03900M | 25.14M | -3.29700M | 14.42M | 22.18M |
Sector: Healthcare Industry: Medical Distribution
| Company | Change (AUD) | Price (AUD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PGC Paragon Care Ltd |
-0.005 2.70% | 0.18 | - | 5.98 | 0.09 | 0.98 | 0.18 | 17.79 |
| SIG Sigma Healthcare Ltd |
-0.03 1.09% | 2.72 | 56.00 | 38.17 | 3.39 | 6.43 | 5.56 | 40.06 |
| EBO Ebos Group Ltd |
-0.32 1.68% | 18.72 | 18.43 | 17.01 | 0.31 | 1.51 | 0.47 | 10.81 |
| MYX Mayne Pharma Group Ltd |
0.18 7.29% | 2.65 | - | 263.16 | 0.49 | 0.55 | 0.42 | 5.70 |
| CYC Cyclopharm Ltd |
0.04 5.48% | 0.77 | - | 116.28 | 2.78 | 3.29 | 5.41 | -24.5712 |
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, breast milk tracking, electrodes; sterilisable transducers designed for surgical procedures, digital theatre integration, infection control, infusion therapy, temperature management, enteral feeding, pain management, lasers, operating room products, surgical consumables, and ultrasound systems. In addition, the company offers aesthetic devices for dermatologists, cosmetic surgeons, general practitioners, beauty and aesthetic providers, and educational institutions; natural, traditional, and complementary health products and services; critical care and dental solutions; urology solutions, such as shockwave therapy, lasers, and accessories for infection control; medical products and consumables; and orthopaedics solutions, including hip and knee arthroplasty, upper and lower extremity, sports medicine, reverse shoulder replacement, and powered surgical tools. Further, it offers medical equipment repair, maintenance, and support services; technology and communication solutions, such as telephony, nurse call, access control, cctv, cordless, and Wi-Fi; supplies medical equipment to veterans, war widows, and families; and veterinary products. Additionally, it is involved in maintenance of technical medical equipment to the health, aged care, and veterinary markets; and distribution of pharmaceuticals, medical consumables, and complementary medicines to Australian healthcare market. The company is based in Mount Waverley, Australia.
77-97 Ricketts Road, Mount Waverley, VIC, Australia, 3149
| Name | Title | Year Born |
|---|---|---|
| Mr. Mark Robert Hooper BBus (Acc), C.P.A., CPA, FFTP, M.A.I.C.D., MAICD | Group CEO, MD & Director | 1959 |
| Mr. Stephen J. Munday | Exec. Officer | 1964 |
| Mr. John Andrew Walstab | Exec. Director & Exec. GM of Paragon Care Asia | 1963 |
| Ms. Josephine De Martino | Chief Financial Officer | NA |
| Ms. Melanie Jaye Leydin B.Bus, C.A., CA | Joint Company Sec. | 1973 |
| Ms. Claire Newstead-Sinclair BBus, C.A., CA | Joint Company Sec. | NA |
| Mr. Michael G. Rice | Group Commercial Mang. | 1976 |
| Mr. John Andrew Walstab | Group CEO, MD & Executive Director | 1963 |
| Ms. Melanie Jaye Leydin B.Bus, C.A. | Joint Company Secretary | 1973 |
| Ms. Claire Newstead-Sinclair BBus, C.A., CA | Joint Company Secretary | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...